Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$13.12 - $15.03 $45,657 - $52,304
3,480 Added 30.22%
14,995 $214,000
Q3 2021

Nov 15, 2021

BUY
$16.3 - $17.26 $10,937 - $11,581
671 Added 6.19%
11,515 $189,000
Q2 2021

Jul 29, 2021

SELL
$16.55 - $18.64 $8,788 - $9,897
-531 Reduced 4.67%
10,844 $183,000
Q1 2021

Apr 12, 2021

BUY
$16.71 - $19.9 $4,327 - $5,154
259 Added 2.33%
11,375 $196,000
Q4 2020

Feb 10, 2021

BUY
$15.39 - $18.97 $171,075 - $210,870
11,116 New
11,116 $197,000
Q2 2020

Aug 13, 2020

SELL
$14.59 - $19.5 $154,756 - $206,836
-10,607 Closed
0 $0
Q1 2020

May 01, 2020

BUY
$13.02 - $20.31 $135,681 - $211,650
10,421 Added 5602.69%
10,607 $186,000
Q1 2020

Apr 27, 2020

SELL
$13.02 - $20.31 $135,030 - $210,635
-10,371 Reduced 98.24%
186 $10.6 Million
Q4 2019

Feb 13, 2020

BUY
$16.88 - $20.83 $793 - $979
47 Added 0.45%
10,557 $212,000
Q3 2019

Nov 12, 2019

SELL
$16.15 - $17.99 $3,666 - $4,083
-227 Reduced 2.11%
10,510 $210,000
Q2 2019

Aug 15, 2019

BUY
$16.58 - $20.49 $178,019 - $220,001
10,737 New
10,737 $184,000
Q1 2019

May 08, 2019

SELL
$16.7 - $21.52 $176,402 - $227,315
-10,563 Closed
0 $0
Q4 2018

Feb 20, 2019

BUY
$15.64 - $21.1 $165,205 - $222,879
10,563 New
10,563 $213,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $44.3B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track High Point Advisor Group LLC Portfolio

Follow High Point Advisor Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Point Advisor Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Point Advisor Group LLC with notifications on news.